Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe

Abstract

The 5-day 125/80-mg regimen of aprepitant produced moderate inhibition of CYP3A4 activity in humans, as measured with the use of midazolam as a probe drug.